as on September 17, 2025 at 4:01 pm IST
Market Cap
₹2,922.24 Cr
Return on Equity (ROE)
9.81
PE Ratio (TTM)
31.56
Return on capital employed (ROCE)
12.79
Industry PE ratio
42.14
Beta (LTM)
1.91
P/B Ratio
2.22
Dividend Yield
0.42
PEG Ratio
-51.73
Quarterly Earnings Growth YOY
-68.45
EPS (TTM)
2.15
Sector
Pharmaceuticals
Book Value
21.1
Technical Analysis
Bullish
View Technical Analysis
as on September 17, 2025 at 4:01 pm IST
Morepen Laboratories in the last 5 years
Lowest (10.48x)
March 23, 2020
Today (31.56x)
September 16, 2025
Industry (42.14x)
September 16, 2025
Highest (64.70x)
January 22, 2018
Today’s Price to Earnings Ratio: 31.56x
Compare market cap, revenue, PE, and other key metrics of Morepen Laboratories with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 2,922.24 | 23.45% | 0.57 | 118 | 1,811 | |
BUY | 8,080.46 | 8.35% | 0.60 | 78 | 1,286 | |
NA | 10.41 | -10.65% | 0.50 | -2 | 35 | |
NA | 1,699.52 | 192.71% | 0.51 | 49 | 465 | |
NA | 1,754.97 | 4.93% | 0.74 | 28 | 311 |
Investment in Morepen Laboratories Ltd Shares on INDmoney has grown by 1.51% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:1.51% versus previous 30 day period
Search interest for Morepen Laboratories Ltd Stock has increased by 65% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:65% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Morepen Laboratories.
Morepen Laboratories Ltd’s net profit fell -70.28% since last year same period to ₹10.75Cr in the Q1 2025-2026. On a quarterly growth basis, Morepen Laboratories Ltd has generated -47.1% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Morepen Laboratories Ltd has declared dividend of ₹0.20 per share on 12 May 2025 - translating a dividend yield of 0.38%.
Read More about DividendsCheck stock indices that include Morepen Laboratories.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 1 month, MOREPENLAB stock has moved up by 11.3%
Retail Holding Up
Retail Investor have increased holdings from 60.72% to 61.11% in Jun 2025 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 11.9% return, outperforming this stock by 51.9%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 35.65% of holdings in Jun 2025 quarter
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 138.8% return, outperforming this stock by 70.9%
FII Holding Down
Foreign Institutions have decreased holdings from 1.94% to 1.72% in Jun 2025 quarter
Profit Down
Netprofit is down for the last 5 quarters, 36.17 Cr → 10.75 Cr (in ₹), with an average decrease of 24.5% per quarter
Revenue Fall
Revenue is down for the last 2 quarters, 470.46 Cr → 429.65 Cr (in ₹), with an average decrease of 8.7% per quarter
Organisation | Morepen Laboratories Ltd |
Headquarters | Gurgaon |
Industry | Pharmaceuticals |
CEO | Sushil Suri |
E-voting on shares | Click here to vote |
Morepen Laboratories share price today stands at ₹53.76 as on at the close of the market. Morepen Laboratories share today touched a day high of ₹55.4 and a low of ₹53.17.
Morepen Laboratories touched a 52 week high of ₹94.45 and a 52 week low of ₹42. Morepen Laboratories share price today i.e. is closed at ₹53.76, which is -43.08% down from its 52 week high and 28.00% up from its 52 week low.
Morepen Laboratories market capitalisation is ₹2,922.24 Cr as on .
To buy Morepen Laboratories shares, you need to follow these steps:
Morepen Laboratories trading volume is 51.89L as on . This means that 51.89L shares of Morepen Laboratories were bought and sold on the stock market during today's trading session.